The manufacturer became aware of a post market clinical follow-up (pmcf) from (b)(4).The title of this report is ¿a post-market clinical follow-up (pmcf) of the treatment of femoral fractures with the t2 nailing systems¿ which was published in november 2018 and is associated with the t2 femoral nailing system (t2 femur a/r).Within that publication, post-operative complications/ adverse events were reported, which occurred between november 2012 to september 2017.It was not possible to ascertain specific device or patient information from the article, a review of the complaint handling database, however, revealed that the events have not been reported by the hospital or by the author of the publication, therefore 55 complaints were initiated retrospectively for different adverse events mentioned in the report.This product inquiry addresses severe pain persistent 3 months after surgery (device-related).1 out of 2 cases.The report states, "subject 5-8 was a (b)(6) year old caucasian female, who fell from standing, injuring her right (closed isolated) femur.A t2 femur nail was placed in the retrograde, static compression mode, with 1 proximal locking a/p screw and 3 distal locking m/l screws.History significant for previous tobacco use, diabetes, osteoporosis, chronic right knee pain, right hip and back pain without history of trauma, degenerative joint disease, meniscal tear, and vitamin d deficiency; distal femur stress fracture prior to the day of admission found on an mri of the knee.Subject was discharged on pod#4, partial weightbearing.At the 3 month post-op follow-up visit, subject c/o pain and discomfort of the knee, medially.Fracture is healed.Subject was instructed to follow-up in 3 months or sooner if pain worsens.Surgeon noted distal most screw may be slightly long.Subject never returned for another follow-up.".
|